HCV Screening and Linkage to Care Program in a Pharmacy Setting

TUBERCULOSIS(Part 2)
Dr Ruchi Dua
Associate Professor(MD,DNB)
Department of Pulmonary Medicine
Aiims Rishikesh
SITES
Virtually anywhere
Lungs
Pleura
Lymph node
PULMONARY
  
PULMONARY-
 
CLINICAL SCENARIO
SYMPTOMS(Pulmonary)
Cough
+
  exp  (
>
2 weeks)
Fever
Appetite/weight loss
Chest pain
Haemoptysis
Dyspnea
SIGNS
General
Emaciated
Anaemic
Clubbing
Cyanosis
LN
Edema
PRESENTATION(signs)
Respiratory
consolidation
fibro-cavitatory disease
Collapse
 Effusions
Pneumothorax
hydro-pneumothorax
Wide variety of clinical findings
 
PRESENTATION(Pulmonary)
 
 
EPTB-PRESENTATION
 
LN TB
 
LN-site
 
painless enlargement
,systemic symptoms<50%
 
Matting
 
Sinus/fistula
 
FNAC/Bx/NAAT/smear/culture
SKELETAL TB
Site
Pain/joint swelling/dec
range of motion.
Draining sinuses and
abscesses
Systemic symptoms
Radiographic changes
m/b nonspecific
CNS TB
Tuberculous meningitis(MC), intracranial
tuberculomas, , cranial nerve palsies and
communicating hydrocephalus , cranial
vasculitis may lead to focal neurologic deficits.
Malaise, headache, fever, or personality
change,A/S,seizures/focal defects
CSF –lymphocytic,increased protein,ADA,CB
NAAT
Koch’s abdomen
Site-gut/peritoneum/LN
pain,nausea/vomitting
altered bowel habbits
Distension
Diagnosis:ascetic fluid
analysis/LN
sampling/radiology
Miliary
Fever/dec appetite/wt loss/vague-elderly
Haematogenous
Fulminant disease -septic shock, ARDS,MOF
CXR/Liver/spleen BX/BM
Haematological-anaemia(NCNC),hyponatremia
PRESENTATION(Extra-Pulmonary)
Genitourinary-infertility, urinary difficulties
CVS-pericarditis(pain/dyspnea)
CLINICAL CLUES-EPTB
A
s
c
i
t
e
s
 
-
l
y
m
p
h
o
c
y
t
e
 
p
r
e
d
o
m
i
n
a
n
c
e
 
a
n
d
 
n
e
g
a
t
i
v
e
 
b
a
c
t
e
r
i
a
l
 
c
u
l
t
u
r
e
s
C
h
r
o
n
i
c
 
l
y
m
p
h
a
d
e
n
o
p
a
t
h
y
 
(
e
s
p
e
c
i
a
l
l
y
 
c
e
r
v
i
c
a
l
)
C
S
F
 
-
l
y
m
p
h
o
c
y
t
i
c
 
p
l
e
o
c
y
t
o
s
i
s
 
/
 
e
l
e
v
a
t
e
d
 
p
r
o
t
e
i
n
 
/
l
o
w
 
g
l
u
c
o
s
e
P
l
e
u
r
a
l
 
e
f
f
u
s
i
o
n
 
-
E
x
u
d
a
t
i
v
e
 
/
 
l
y
m
p
h
o
c
y
t
e
 
p
r
e
d
o
m
i
n
a
n
c
e
/
n
e
g
a
t
i
v
e
b
a
c
t
e
r
i
a
l
 
c
u
l
t
u
r
e
s
J
o
i
n
t
 
i
n
f
l
a
m
m
a
t
i
o
n
 
(
m
o
n
o
a
r
t
i
c
u
l
a
r
)
 
w
i
t
h
 
n
e
g
a
t
i
v
e
 
b
a
c
t
e
r
i
a
l
 
c
u
l
t
u
r
e
s
P
e
r
s
i
s
t
e
n
t
 
s
t
e
r
i
l
e
 
p
y
u
r
i
a
U
n
e
x
p
l
a
i
n
e
d
 
p
e
r
i
c
a
r
d
i
a
l
 
e
f
f
u
s
i
o
n
,
 
c
o
n
s
t
r
i
c
t
i
v
e
 
p
e
r
i
c
a
r
d
i
t
i
s
,
 
o
r
p
e
r
i
c
a
r
d
i
a
l
 
c
a
l
c
i
f
i
c
a
t
i
o
n
/
V
e
r
t
e
b
r
a
l
 
o
s
t
e
o
m
y
e
l
i
t
i
s
 
i
n
v
o
l
v
i
n
g
 
t
h
e
 
t
h
o
r
a
c
i
c
s
p
i
n
e
COMPLICATIONS
Local-
ARDS/respiratory failure
Bronchiectasis/PTOAD
aspergilloma
haemoptysis (symp )
Pleural -Empyema/pneumo
Extensive lung destruction
Rt middle lobe syndrome
Scar ca
 
 
Systemic-
shock
amyloidosis
disseminated tb-(laryngeal tb)
Cor-pulmonale
INVESTIGATIONS
Active infection
Latent Infection
Drug resistance
 
  TESTS FOR ACTIVE TUBERCULOSIS
ACTIVE TUBERCULOSIS
Radiology-X-ray
Microbiological-smear /culture
NAAT-gene expert
CXR
Abnormalities often seen in
apical 
or posterior
 segments
of upper 
l
obe or superior
segments of lower lobe
May have unusual
appearance in
 
HIV-positive
persons
Cannot confirm diagnosis of
TB
!!
Sensitive,specificity is low
 
 
No chest X-ray pattern is absolutely typical of
TB
10-15% of culture-positive TB patients not
diagnosed by X-ray
40% of patients diagnosed as having TB on the
basis of x-ray alone do not have active TB
Proportion of patients with pulmonary
TB who have positive AFB smears
SPUTUM SMEAR
 
 
Rapid , r
esults within hours
 
Inexpensive
 
 simple, relatively easy to perform
 
Reliable(40-64%sensitive,90%specificity)
 
 
AFB - Ziehl-Nielson stain
 
 
CULTURE
Gold standard for TB diagnosis
(100 bacilli)
Culture all specimens, even if smear negative
Conventional(LJ-6-8wks)
Rapid –liquid culture-Bactec/MGIT
Allows DST Vs smear
Colony Morphology – LJ Slant
IMMUNOLOGICAL TESTS
 
 
BANNED
Antigen/antibody detection method(ELISA )
 
Not specific, rapid, expensive
 
Cannot differentiate active/past infection.
 
           TESTS FOR LTBI
WHAT is LTBI?
1.PPD
-
infection with M tuberculosis produces a Delayed Type
Hypersensitivity (DTH) to certain antigenic components
2.Interferon gamma release assays
 
–Quantiferon gold/Elispot
test
single patient visit
assesses responses to multiple antigens
does not boost anamnestic immune responses
Less reader bias/reading
 moderate concordance between TST and QFT
Mantoux test
 
Limitations
Active Vs inactive disease
Old Vs new
BCG /MOTT(though IGRA are less affected)
 
     TESTS FOR DRUG RESISTANCE
DRUG RESISTANCE
Conventional/rapid culture & DST
GOLD standard
NAAT-gene xpert  LPA
MANAGEMENT
 
Principles of chemotherapy
Variable bacilli population:rapid growers,slow
growers,dormant
Longer duration
2 phases of treatment
Need for multiple drugs to treat(spontaneous
resistance)
Slide Note
Embed
Share

Chronic HCV infection can lead to severe liver complications and affect various body systems beyond the liver. It is crucial to identify patients with HCV, convey the urgency of testing, and provide appropriate care to prevent long-term consequences. Screening programs in pharmacy settings play a vital role in early detection and linkage to care for individuals at risk.

  • HCV Screening
  • Hepatitis C Testing
  • Liver Disease
  • Pharmacy Program
  • Health Awareness

Uploaded on Feb 25, 2025 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. TUBERCULOSIS(Part 2) Dr Ruchi Dua Associate Professor(MD,DNB) Department of Pulmonary Medicine Aiims Rishikesh

  2. SITES Virtually anywhere Lungs Pleura Lymph node

  3. PULMONARY PULMONARY- CLINICAL SCENARIO

  4. SYMPTOMS(Pulmonary) Cough+ exp (>2 weeks) Fever Appetite/weight loss Chest pain Haemoptysis Dyspnea

  5. SIGNS General Emaciated Anaemic Clubbing Cyanosis LN Edema

  6. PRESENTATION(signs) Respiratory consolidation fibro-cavitatory disease Collapse Effusions Pneumothorax hydro-pneumothorax Wide variety of clinical findings

  7. PRESENTATION(Pulmonary)

  8. EPTB-PRESENTATION

  9. LN TB LN-site painless enlargement ,systemic symptoms<50% Matting Sinus/fistula FNAC/Bx/NAAT/smear/culture

  10. SKELETAL TB Site Pain/joint swelling/dec range of motion. Draining sinuses and abscesses Systemic symptoms Radiographic changes m/b nonspecific

  11. CNS TB Tuberculous meningitis(MC), intracranial tuberculomas, , cranial nerve palsies and communicating hydrocephalus , cranial vasculitis may lead to focal neurologic deficits. Malaise, headache, fever, or personality change,A/S,seizures/focal defects CSF lymphocytic,increased protein,ADA,CB NAAT

  12. Kochs abdomen Site-gut/peritoneum/LN pain,nausea/vomitting altered bowel habbits Distension Diagnosis:ascetic fluid analysis/LN sampling/radiology

  13. Miliary Fever/dec appetite/wt loss/vague-elderly Haematogenous Fulminant disease -septic shock, ARDS,MOF CXR/Liver/spleen BX/BM Haematological-anaemia(NCNC),hyponatremia

  14. PRESENTATION(Extra-Pulmonary) Genitourinary-infertility, urinary difficulties CVS-pericarditis(pain/dyspnea)

  15. CLINICAL CLUES-EPTB Ascites -lymphocyte predominance and negative bacterial cultures Chronic lymphadenopathy (especially cervical) CSF -lymphocytic pleocytosis / elevated protein /low glucose Pleural effusion -Exudative / lymphocyte predominance/negative bacterial cultures Joint inflammation (monoarticular) with negative bacterial cultures Persistent sterile pyuria Unexplained pericardial effusion, constrictive pericarditis, or pericardial calcification/Vertebral osteomyelitis involving the thoracic spine

  16. COMPLICATIONS Local- ARDS/respiratory failure Bronchiectasis/PTOAD aspergilloma haemoptysis (symp ) Pleural -Empyema/pneumo Extensive lung destruction Rt middle lobe syndrome Scar ca

  17. Systemic- shock amyloidosis disseminated tb-(laryngeal tb) Cor-pulmonale

  18. INVESTIGATIONS Active infection Latent Infection Drug resistance

  19. TESTS FOR ACTIVE TUBERCULOSIS

  20. ACTIVE TUBERCULOSIS Radiology-X-ray Microbiological-smear /culture NAAT-gene expert

  21. CXR Abnormalities often seen in apical or posterior segments of upper lobe or superior segments of lower lobe May have unusual appearance in HIV-positive persons Cannot confirm diagnosis of TB!! Sensitive,specificity is low

  22. No chest X-ray pattern is absolutely typical of TB 10-15% of culture-positive TB patients not diagnosed by X-ray 40% of patients diagnosed as having TB on the basis of x-ray alone do not have active TB

  23. Proportion of patients with pulmonary TB who have positive AFB smears 98% 98% 100 100 80 80 60 60 50% 50% 40 40 20 20 0 0 AFB Microscopy X-ray

  24. SPUTUM SMEAR Rapid , results within hours Inexpensive simple, relatively easy to perform Reliable(40-64%sensitive,90%specificity)

  25. AFB - Ziehl-Nielson stain

  26. CULTURE Gold standard for TB diagnosis(100 bacilli) Culture all specimens, even if smear negative Conventional(LJ-6-8wks) Rapid liquid culture-Bactec/MGIT Allows DST Vs smear

  27. Colony Morphology LJ Slant

  28. IMMUNOLOGICAL TESTS BANNED Antigen/antibody detection method(ELISA ) Not specific, rapid, expensive Cannot differentiate active/past infection.

  29. TESTS FOR LTBI

  30. WHAT is LTBI? 1.PPD- infection with M tuberculosis produces a Delayed Type Hypersensitivity (DTH) to certain antigenic components 2.Interferon gamma release assays Quantiferon gold/Elispot test single patient visit assesses responses to multiple antigens does not boost anamnestic immune responses Less reader bias/reading moderate concordance between TST and QFT

  31. Mantoux test

  32. Limitations Active Vs inactive disease Old Vs new BCG /MOTT(though IGRA are less affected)

  33. TESTS FOR DRUG RESISTANCE

  34. DRUG RESISTANCE Conventional/rapid culture & DST GOLD standard NAAT-gene xpert LPA

  35. MANAGEMENT

  36. Principles of chemotherapy Variable bacilli population:rapid growers,slow growers,dormant Longer duration 2 phases of treatment Need for multiple drugs to treat(spontaneous resistance)

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#